Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on...
-
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 30, 2023 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX:...
-
Toronto, Ontario and Nucla, Colorado, June 30, 2023 (GLOBE NEWSWIRE) -- Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“Western” or the ”Company”) is pleased to announce the results...
-
MONTREAL, June 30, 2023 (GLOBE NEWSWIRE) -- Yorbeau Resources Inc. (TSX: YRB) (the "Company" or "Yorbeau") is pleased to announce that it has completed the first and second tranches of a $1,200,000...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 30, 2023 (GLOBE NEWSWIRE) -- Heliostar Metals Ltd. (TSXV:HSTR)...
-
Company reaches its goal to sign definitive acquisitions of four Maryland dispensaries prior to adult-use launch US$8.25 million transaction expected to be immediately accretive on an EBITDA and...
-
VANCOUVER, British Columbia, June 30, 2023 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) second quarter 2023 financial and operating results will be...
-
Clairvest Completes First Close of Clairvest Equity Partners VII at Target Fund Size of US$1 Billion
TORONTO, June 30, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG, “Clairvest”) today announced it has held a first closing for Clairvest Equity Partners VII (“CEP VII”). Marketing of CEP...
-
CORYDON, Ind., June 30, 2023 (GLOBE NEWSWIRE) -- First Capital, Inc. (the “Company”) (NASDAQ:FCAP), the holding company for First Harrison Bank (the “Bank”), today announced that William W. Harrod...
-
BOSTON, June 30, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers,...